Literature DB >> 17604151

Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis.

David A Zisman1, David J Ross, John A Belperio, Rajan Saggar, Joseph P Lynch, Abbas Ardehali, Arun S Karlamangla.   

Abstract

BACKGROUND: Reliable, noninvasive approaches to the diagnosis of pulmonary hypertension in idiopathic pulmonary fibrosis are needed. We tested the hypothesis that the forced vital capacity to diffusing capacity ratio and room air resting pulse oximetry may be combined to predict mean pulmonary artery pressure (MPAP) in idiopathic pulmonary fibrosis.
METHODS: Sixty-one idiopathic pulmonary fibrosis patients with available right-heart catheterization were studied. We regressed measured MPAP as a continuous variable on pulse oximetry (SpO(2)) and percent predicted forced vital capacity (FVC) to percent-predicted diffusing capacity ratio (% FVC/% DL(co)) in a multivariable linear regression model.
RESULTS: Linear regression generated the following equation: MPAP=-11.9+0.272 x SpO(2)+0.0659 x (100-SpO(2))(2)+3.06 x (% FVC/% DL(co)); adjusted R(2)=0.55, p<0.0001. The sensitivity, specificity, positive predictive and negative predictive value of model-predicted pulmonary hypertension were 71% (95% confidence interval (CI): 50-89%), 81% (95% CI: 68-92%), 71% (95% CI: 51-87%) and 81% (95% CI: 68-94%).
CONCLUSIONS: A pulmonary hypertension predictor based on room air resting pulse oximetry and FVC to diffusing capacity ratio has a relatively high negative predictive value. However, this model will require external validation before it can be used in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17604151      PMCID: PMC2096631          DOI: 10.1016/j.rmed.2007.05.012

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  30 in total

1.  Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium.

Authors:  C A Tozzi; G J Poiani; A M Harangozo; C D Boyd; D J Riley
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

Review 3.  Chronic hypoxic pulmonary hypertension. Cell biology to pathophysiology.

Authors:  R L Vender
Journal:  Chest       Date:  1994-07       Impact factor: 9.410

4.  Isolated diffusing capacity reduction in systemic sclerosis.

Authors:  V D Steen; G Graham; C Conte; G Owens; T A Medsger
Journal:  Arthritis Rheum       Date:  1992-07

5.  Normal pulmonary capillary blood volume in patients with chronic infiltrative lung disease and high pulmonary artery pressure.

Authors:  Marcel Bonay; Catherine Bancal; Dominique de Zuttere; Florence Arnoult; Georges Saumon; Françoise Camus
Journal:  Chest       Date:  2004-11       Impact factor: 9.410

6.  Pulmonary arterial hypertension is a major mortality factor in diffuse systemic sclerosis, independent of interstitial lung disease.

Authors:  Salim Trad; Zahir Amoura; Catherine Beigelman; Julien Haroche; Nathalie Costedoat; Le Thi Huong Du Boutin; Patrice Cacoub; Camille Frances; Bertrand Wechsler; Philippe Grenier; Jean-Charles Piette
Journal:  Arthritis Rheum       Date:  2006-01

7.  Pulmonary hypertension in patients with idiopathic pulmonary fibrosis.

Authors:  Hassan F Nadrous; Patricia A Pellikka; Michael J Krowka; Karen L Swanson; Nithima Chaowalit; Paul A Decker; Jay H Ryu
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

8.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

Review 9.  Pulmonary hypertension in connective tissue disease. Report of three cases and review of the literature.

Authors:  L C Pronk; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

10.  Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms.

Authors:  L P McQuillan; G K Leung; P A Marsden; S K Kostyk; S Kourembanas
Journal:  Am J Physiol       Date:  1994-11
View more
  23 in total

1.  Aspects of left ventricular morphology outperform left ventricular mass for prediction of QRS duration.

Authors:  Nina Hakacova; Katarina Steding; Henrik Engblom; Jane Sjögren; Charles Maynard; Olle Pahlm
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

2.  Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.

Authors:  Jason M Elinoff; Richa Agarwal; Christopher F Barnett; Raymond L Benza; Michael J Cuttica; Ahmed M Gharib; Michael P Gray; Paul M Hassoun; Anna R Hemnes; Marc Humbert; Todd M Kolb; Tim Lahm; Jane A Leopold; Stephen C Mathai; Vallerie V McLaughlin; Ioana R Preston; Erika B Rosenzweig; Oksana A Shlobin; Virginia D Steen; Roham T Zamanian; Michael A Solomon
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

Review 3.  Pulmonary hypertension associated with lung diseases and hypoxemia.

Authors:  Michael J Cuttica
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

4.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

5.  Pulmonary hypertension associated with lung transplantation obliterative bronchiolitis and vascular remodeling of the allograft.

Authors:  R Saggar; D J Ross; R Saggar; D A Zisman; A Gregson; J P Lynch; M P Keane; S Samuel Weigt; A Ardehali; B Kubak; C Lai; D Elashoff; M C Fishbein; W D Wallace; J A Belperio
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

6.  Advances in the management of idiopathic pulmonary fibrosis.

Authors:  Jay H Ryu; Craig E Daniels
Journal:  F1000 Med Rep       Date:  2010-04-12

7.  Evaluation of recently validated non- invasive formula using basic lung functions as new screening tool for pulmonary hypertension in idiopathic pulmonary fibrosis patients.

Authors:  Maha K Ghanem; Hoda A Makhlouf; Gamal R Agmy; Hisham M K Imam; Doaa A Fouad
Journal:  Ann Thorac Med       Date:  2009-10       Impact factor: 2.219

8.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

9.  Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Steven D Nathan; Oksana A Shlobin; Scott D Barnett; Rajeev Saggar; John A Belperio; David J Ross; Shahzad Ahmad; Rajan Saggar; Eric Libre; Joseph P Lynch; David A Zisman
Journal:  Respir Med       Date:  2008-07-10       Impact factor: 3.415

10.  Non-invasive diagnosis of early pulmonary disease in PECAM-deficient mice using infrared pulse oximetry.

Authors:  Merideth A Early; Marta Lishnevsky; John M Gilchrist; David M Higgins; Ian M Orme; William A Muller; Mercedes Gonzalez-Juarerro; Alan R Schenkel
Journal:  Exp Mol Pathol       Date:  2009-07-28       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.